Cargando…

Editorial: Natural compounds regulating epigenetics for treating chronic inflammatory diseases

Detalles Bibliográficos
Autores principales:	Zhang, Mingyu, Sul, Ok Joo, Fu, Junjiang, Wang, Qianqian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9873991/ https://www.ncbi.nlm.nih.gov/pubmed/36712660 http://dx.doi.org/10.3389/fphar.2022.1121165

Ejemplares similares

Editorial: Natural Product Epigenetic Modulators and Inhibitors
por: Ntie-Kang, Fidele, et al.
Publicado: (2021)

Editorial: Natural product treatment of gastrointestinal diseases
por: Sun, Mingyu, et al.
Publicado: (2022)

Editorial: Epigenetic regulation and therapy resistance in cancer
por: Zhu, Yongxia, et al.
Publicado: (2023)

Natural Anti-Inflammatory Compounds as Drug Candidates for Inflammatory Bowel Disease
por: Duan, Linshan, et al.
Publicado: (2021)

Editorial: Traditional medicine and chronic inflammatory diseases
por: Liu, Wei, et al.
Publicado: (2023)

Editorial: Non-Coding RNAs as Mediators of the Activity of Natural Compounds
por: Scoditti, Egeria, et al.
Publicado: (2021)

Editorial: Targeting triple negative breast cancer by natural compounds
por: Kumar, Shashank, et al.
Publicado: (2023)

New Insights Into the Epigenetic Regulation of Inflammatory Bowel Disease
por: Xu, Jing, et al.
Publicado: (2022)

Editorial: Exploring the unique biodiversity of the Western Pacific to identify novel anti-infectious and anti-inflammatory compounds of natural origin
por: Georgel, Philippe, et al.
Publicado: (2023)

Editorial: New trends in natural product research for inflammatory and infectious diseases
por: Ribeiro-Filho, Jaime, et al.
Publicado: (2022)

Editorial: The Role of Natural Products in Chronic Inflammation
por: Deng, Wenjun, et al.
Publicado: (2022)

Editorial: Natural products in the treatment of neurological diseases: identification of novel active compounds and therapeutic targets
por: Zhao, Jia, et al.
Publicado: (2023)

Editorial: Natural products in regulating mitochondrial dysfunction
por: Xie, Caifeng, et al.
Publicado: (2023)

Perspectives of herbs and their natural compounds, and herb formulas on treating diverse diseases through regulating complicated JAK/STAT signaling
por: Chen, Jian-Yu, et al.
Publicado: (2022)

Editorial: Anti-inflammatory immunopharmacology in the prevention and treatment of major chronic diseases
por: Zhang, Qiuwang, et al.
Publicado: (2023)

Editorial: New trends in natural product research for inflammatory and infectious diseases: Volume II
por: Ribeiro-Filho, Jaime, et al.
Publicado: (2023)

Natural products of traditional Chinese medicine treat atherosclerosis by regulating inflammatory and oxidative stress pathways
por: Meng, Tianwei, et al.
Publicado: (2022)

Editorial: Natural compounds as scaffolds for the discovery of new anti-cancer drugs: Focus on terpenoids and flavonoids
por: Sülsen, Valeria P., et al.
Publicado: (2022)

Editorial: Exploring the therapeutic effects of synthetic, semi-synthetic and naturally derived compounds against cancer
por: Feng, Liang, et al.
Publicado: (2023)

Editorial: Natural Products-Based Drugs: Potential Therapeutics Against Alzheimer’s Disease and Other Neurological Disorders
por: Ayaz, Muhammad, et al.
Publicado: (2019)

Editorial: Efficacy and mechanism of herbal medicines and their functional compounds in preventing and treating cardiovascular diseases and cardiovascular disease risk factors
por: Meng, Tiantian, et al.
Publicado: (2023)

Potential Natural Small Molecular Compounds for the Treatment of Chronic Obstructive Pulmonary Disease: An Overview
por: Li, Liu-Ying, et al.
Publicado: (2022)

Editorial: Targeting Human Inflammatory Skin Diseases With Natural Products: Exploring Potential Mechanisms and Regulatory Pathways
por: Goh, Bey Hing, et al.
Publicado: (2021)

Editorial: Epigenetic drugs and therapeutic resistance for epithelial malignancies
por: Tao, Fangfang, et al.
Publicado: (2023)

Editorial: Sex Differences in Inflammatory Diseases
por: Trabace, Luigia, et al.
Publicado: (2022)

The Prospective Application of Melatonin in Treating Epigenetic Dysfunctional Diseases
por: Monayo, Seth Mikaye, et al.
Publicado: (2022)

Editorial: The Role of Medicinal Plants and Natural Products in Modulating Oxidative Stress and Inflammatory Related Disorders
por: Agbor, Gabriel A., et al.
Publicado: (2022)

Editorial: Regulation of PI3K/Akt signaling pathway: A feasible approach for natural neuroprotective agents to treat various neuron injury-related diseases
por: Chen, Yunhui, et al.
Publicado: (2023)

Editorial: Acute phase proteins as biomarkers and therapeutics in acute and chronic inflammatory conditions
por: Stanke, Frauke, et al.
Publicado: (2023)

Editorial: Therapeutic potential of natural products-based drugs in regulation of lipid metabolism
por: Rašković, Aleksandar, et al.
Publicado: (2023)

Targeting pancreatic stellate cells in chronic pancreatitis: Focus on therapeutic drugs and natural compounds
por: Wu, Yang, et al.
Publicado: (2022)

MicroRNAs and Natural Compounds Mediated Regulation of TGF Signaling in Prostate Cancer
por: Javed, Zeeshan, et al.
Publicado: (2021)

Editorial: New Approaches to Tackle EMT and Fibrosis: From Epigenetics to Nanotechnology
por: Battistelli, Cecilia, et al.
Publicado: (2021)

Editorial: Environmental Enrichment as a Treatment? Epigenetic Mechanisms, Challenges and Limitations
por: Redolat, Rosa, et al.
Publicado: (2021)

Editorial: Novel Drugs Targeting the Microenvironment and the Epigenetic Changes in Hematopoietic Malignancies
por: Gulei, Diana, et al.
Publicado: (2020)

Epigenetic Regulation and Its Therapeutic Potential in Pulmonary Hypertension
por: Wang, Yu, et al.
Publicado: (2018)

Editorial: Natural products for neuroprotection and neuroregeneration
por: Wong, Kah Hui, et al.
Publicado: (2023)

Editorial: The role of medicinal plants and natural products in modulating oxidative stress and inflammatory related disorders, Volume II
por: Agbor, Gabriel A., et al.
Publicado: (2023)

Plant-derived bioactive compounds regulate the NLRP3 inflammasome to treat NAFLD
por: Huang, Qian, et al.
Publicado: (2022)

Editorial: Phosphodiesterases as Drug Targets in Airway and Inflammatory Diseases
por: Mokry, Juraj, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ark2fr39m3bucuqn6uo2bbqhik